跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 3,494 条关于
“TGF-β RI”
全部
3,494
临床试验
2,266
药物
652
机构
10
资讯
566
去年
Agomab's AGMB-129 Shows Promising Results in Phase 2a Trial for Fibrostenosing Crohn's Disease
2个月前
Agomab Unveils Design for First-Ever Phase 2b Trial in Fibrostenosing Crohn's Disease with Oral ALK5 Inhibitor Ontunisertib
10个月前
Agomab's Ontunisertib Achieves Primary Safety Endpoint in First-in-Class Phase 2a Trial for Fibrostenosing Crohn's Disease
3个月前
Liminatus Pharma to Acquire InnocsAI in $320 Million Deal, Gaining Next-Generation CAR-T Pipeline for Hematologic and Solid Tumors
12个月前
TGF-β Inhibitor Pipeline Expands with 25+ Companies Developing Novel Therapies for Cancer and Fibrosis
10个月前
Tiumbio's Dual TGF-β/VEGF Inhibitor Tosposertib Shows 70.6% Response Rate in Head and Neck Cancer Trial
7个月前
Oncotelic Therapeutics Expands Global Patent Protection for OT-101 TGF-β Antisense Therapy Across CNS and Neurology Applications
8个月前
Novel TGF-β1 Inhibitor Linavonkibart Shows Promise in Overcoming Immune Checkpoint Resistance
去年
EZH2 Enzyme Drives Drug Resistance in Prostate Cancer via Novel Mechanism
2年前
Canadian Institutes of Health Research Funds Four New Clinical Trials at RI-MUHC
第 1 页,共 57 页
上一页
下一页